Treatments for nicotine addiction should be a top priority

Sadly, priorities for invest ment in clinical trials are directed at treatment of diseases caused by continued tobacco use, rather than addressing the root cause of the diseases: nicotine addiction (figure). [...] clinical trials for smoking cessation and treat ment of nicotine addiction are not eve...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 2009-08, Vol.374 (9689), p.513-514
Main Authors: Pollock, Jonathan D, Koustova, Elena, Hoffman, Allison, Shurtleff, David, Volkow, Nora D
Format: Article
Language:English
Subjects:
Addictions
Cause of Death
Disease
Health Priorities
Health Services Needs and Demand
Healthy People Programs
Humans
Internal Medicine
Lung cancer
Medical treatment
Nicotine
Research Support as Topic
Smoking Cessation
Tobacco Use Disorder - complications
Tobacco Use Disorder - epidemiology
Tobacco Use Disorder - therapy
United States - epidemiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Sadly, priorities for invest ment in clinical trials are directed at treatment of diseases caused by continued tobacco use, rather than addressing the root cause of the diseases: nicotine addiction (figure). [...] clinical trials for smoking cessation and treat ment of nicotine addiction are not even within the top 25 therapeutic categories in development by the drug industry; anticancer treatments are the first priority.3 174 pharmacotherapy trials were done for smoking cessation (46 supported by industry) com pared with 1490 for lung cancer (544 supported by industry).
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(09)60352-4